Etanercept in New Onset Type 1 Diabetes

Clinical trial NCT00730392 · COMPLETED

Trial details

NCT number: NCT00730392
Sponsor: State University of New York at Buffalo
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2002-10-01
Primary completion: 2007-10-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.